|
|
Volumn 16, Issue 9, 1995, Pages 309-316
|
|
Na+ channels as targets for neuroprotective drugs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 DIAMINO 5 (2,3,5 TRICHLOROPHENYL)PYRIMIDINE;
3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZAMIDE;
ANTIARRHYTHMIC AGENT;
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
CARVEDILOL;
CI 953;
CNS 1237;
FLUNARIZINE;
LAMOTRIGINE;
LIDOCAINE;
LIFARIZINE;
LOCAL ANESTHETIC AGENT;
N [3 (2,6 DIMETHYL 1 PIPERIDINYL)PROPYL] ALPHA PHENYLBENZENEACETAMIDE;
NEUROPROTECTIVE AGENT;
PHENYTOIN;
RALITOLINE;
RILUZOLE;
SIPATRIGINE;
SODIUM CHANNEL;
SODIUM CHANNEL BLOCKING AGENT;
TETRACAINE;
TETRODOTOXIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VERAPAMIL;
VERATRIDINE;
ZONISAMIDE;
AMYOTROPHIC LATERAL SCLEROSIS;
ANIMAL MODEL;
BRAIN PROTECTION;
CLINICAL TRIAL;
DEGENERATIVE DISEASE;
ELECTRIC POTENTIAL;
ELECTROPHYSIOLOGY;
HEAD INJURY;
HUMAN;
NERVE CELL DEGENERATION;
NEUROLOGIC DISEASE;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
STROKE;
ANIMAL;
BRAIN INJURIES;
CEREBROVASCULAR DISORDERS;
HUMAN;
NEUROPROTECTIVE AGENTS;
SODIUM CHANNELS;
SUPPORT, NON-U.S. GOV'T;
|
|
EID: 0028979311
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(00)89060-4 Document Type: Review |
|
Times cited : (268)
|
|
References (74)
|
